A CASE STUDY CLICK HERE
to review a copy of the book
REQUEST OUR PORTFOLIO
SEND THIS FORM
The Medical News
(Reuters) - France's Sanofi SA is preparing to name candidates it will put forward to replace the entire board of U.S. cancer drug company Medivation Inc as early as Wednesday, according to people familiar with the matter.... LONDON (Reuters) - The number of people in France and Britain who have tried an electronic or e-cigarette has risen sharply in just two years, according to a Europe-wide study published on Tuesday.... (Reuters Health) - Infants exposed to higher levels of vehicular air pollution more often have problems later on in the small airways near the edges of their lungs, according to a new study.... (Reuters) - Eli Lilly and Co on Tuesday said it and partner Pfizer Inc aim to seek approval by 2018 for a new type of pain drug that could be an alternative to opioids for osteoarthritis, chronic back pain and cancer pain.... (Reuters Health) - When parents have lost a baby to sudden infant death syndrome (SIDS), doctors may fear that discussing the risk factors will distress them or cause them to blame themselves. But a new study suggests parents want more information.... (Reuters) - The U.S. Food and Drug Administration deferred its decision on Sarepta Therapeutics Inc's muscle-wasting disorder drug, a month after a federal advisory panel determined the treatment had not been proven effective.... JERUSALEM (Reuters) - Israeli 3D printer firm Nano Dimension has successfully lab-tested a 3D bioprinter for stem cells, paving the way for the potential printing of large tissues and organs, the company said on Wednesday.... PROBOLINGGO, Indonesia (Reuters) - Thirteen-year-old Siti Maryam says she suffers headaches and nausea after harvesting tobacco leaves with her bare hands during four years of working on her family's farm in Indonesia.... RIO DE JANEIRO (Thomson Reuters Foundation) - Years after giving into family pressure and having an illegal abortion, one Brazilian woman says she is haunted by the secret procedure so taboo that hardly anyone will talk about it.... (Reuters) - A U.S. advisory panel on Tuesday recommended approval of a new diabetes drug made by Novo Nordisk A/S that combines two of its existing treatments in a fixed-dose combination designed to be both effective and convenient....